Veracyte Inc Equity-NMS: VCYT

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$22.33
Open :	$22.27
Today's high :	$22.32
Today's low :	$21.68
52W low :	$14.92
52W high :	$32.4
1Y :	34%
5Y :	143.6%
Shares O/S :	72.75 M
Market cap :	1.6 B

What is the share price of Veracyte Inc today?

Veracyte Inc (VCYT) share price as of October 3, 2023, is $21.96. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Veracyte Inc?

Yes, Indian Investors can invest in the Veracyte Inc (VCYT) Share by opening an international trading account with Angel One.

How can I purchase Veracyte Inc shares in India?

Purchasing Veracyte Inc (VCYT) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Veracyte Inc (VCYT) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Veracyte Inc?

Yes, you can purchase fractional shares of Veracyte Inc (VCYT) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Veracyte Inc?

The market capitalization of Veracyte Inc on October 3, 2023, is $1.6 B.

In which sector Veracyte Inc belongs?

Veracyte Inc operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Veracyte Inc stocks?

In order to invest in Veracyte Inc (VCYT) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Veracyte, Inc. is a global diagnostics company. The Company is engaged in the development and commercialization of diagnostic products and biopharmaceutical services. It offers tests for thyroid cancer (Afirma), prostate cancer (Decipher Prostate), breast cancer (Prosigna), interstitial lung diseases (Envisia), and bladder cancer (Decipher Bladder). Its Percepta Nasal Swab test is being run in its Clinical Laboratory Improvement Amendments (CLIA) lab in support of clinical studies and its tests for kidney cancer and lymphoma are in development, the latter as a companion diagnostic. It also offers an Immunogram, which provides an understanding of the tumor immune microenvironment by integrating data from a variety of genomic, transcriptomic, and proteomic platforms. Its tests in the United States are serviced through its own CLIA-certified laboratories in South San Francisco and San Diego, California and Austin, Texas. It also offers customized biomarker testing and analytical services.